DIVALPROEX for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where DIVALPROEX was used for Psoriasis.
Most Reported Side Effects for DIVALPROEX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,121 | 9.8% | 14 | 305 |
| Seizure | 1,095 | 9.6% | 26 | 344 |
| Off label use | 576 | 5.0% | 15 | 240 |
| Somnolence | 545 | 4.8% | 20 | 243 |
| Drug interaction | 540 | 4.7% | 13 | 277 |
| Nausea | 526 | 4.6% | 4 | 255 |
| Weight increased | 509 | 4.4% | 0 | 108 |
| Tremor | 461 | 4.0% | 4 | 161 |
| Toxicity to various agents | 452 | 3.9% | 56 | 336 |
| Vomiting | 436 | 3.8% | 8 | 276 |
| Fall | 414 | 3.6% | 19 | 230 |
| Drug hypersensitivity | 381 | 3.3% | 2 | 33 |
| Foetal exposure during pregnancy | 369 | 3.2% | 18 | 25 |
| Fatigue | 366 | 3.2% | 1 | 110 |
| Condition aggravated | 353 | 3.1% | 3 | 246 |
Other Indications for DIVALPROEX
Product used for unknown indication (4,168)
Bipolar disorder (1,282)
Seizure (914)
Epilepsy (859)
Maternal exposure timing unspecified (254)
Schizophrenia (253)
Affective disorder (247)
Depression (192)
Mania (182)
Bipolar i disorder (180)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)